CHINARES PHARMA reported the financial results for its subsidiary, Kpc Pharmaceuticals,Inc., for the three months ended March 31, 2026. The company recorded an operating revenue of 836 million yuan, representing a decrease of 48.01% compared to the same period last year. It reported a net loss of 145 million yuan, a significant swing from a profit of 114 million yuan in the prior-year period.